Chief Executive Officer

AUTHENTIC HR PTE. LTD.; Singapore; On-site; SGD 150,000 - 200,000; Full time

Job summary

An innovative firm is seeking a visionary CEO to lead Singapore's pioneering longevity-focused translational hub. This role demands a unique blend of geroscience expertise, regulatory acumen, and venture financing experience. The CEO will drive the transformation of research into tangible therapeutic candidates while ensuring compliance and operational excellence. This position offers an exciting opportunity to shape the future of age-modifying therapeutics in a dynamic environment, collaborating with global partners and leading a talented team. If you're ready to make a significant impact in the field of longevity science, this is the role for you.

Qualifications

• 8+ years in senior leadership roles in venture-backed therapeutics.
• Experience in raising significant external capital.

Responsibilities

• Oversee the establishment of a longevity-focused hub in Singapore.
• Lead equity rounds and structure cross-border IP-holding vehicles.

Skills

Senior Leadership in Therapeutics

Venture Financing

Regulatory Mastery

Geroscience Knowledge

Strategic Thinking

Job description

Working week: 5.5 days

Working Hours: Monday to Friday – 9 am to 6 pm and Saturday - 9 am to 1 pm

Salary Ranges: Monthly Salary: S$16,500 to S$18,000

Summary:

The CEO will establish and run Singapore’s first integrated longevity-focused translational hub for the Company, overseeing every stage from hypothesis-driven discovery through IND-ready manufacturing for age-modifying therapeutics and diagnostics. Success demands a rare blend of deep geroscience know-how, cross-jurisdictional regulatory mastery, and venture-financing experience that aligns with the parent group’s global IP and capital-market strategy.

Key Responsibilities:

A. Scientific & Clinical Strategy

• Draft and execute a 5-year programme that converts hallmarks-of-ageing research into first-in-human candidates.
• Integrate multi-omics, AI-driven target discovery, and large-animal longevity models within GLP workflows.
• Synchronise Singapore R&D with parallel GMP efforts in the UK and US.

B. Capital Formation & Governance

• Lead equity and convertible-note rounds totalling > US$5 million within 18 months.
• Structure cross-border IP-holding and grant-funding vehicles to maximise Singapore RIE incentives and Section 13R tax benefits.
• Chair the Audit & Risk Committee; oversee quarterly board packs.

C. Operations & Compliance

• Commission a BSL-2/ISO-7 cleanroom and ensure readiness for HAS and EMA inspections.
• Implement ISO-27001 aligned data-integrity systems for multi-site pre-clinical studies.
• Maintain 100% adherence to MOM fair employment guidelines and TAFEP best practices.

D. Talent & Culture

• Build a lean team (< 15 FTEs in year 1) spanning bioinformatics, CMC, clinical operations, and finance.
• Introduce a 24-month rotational leadership development plan and continuous-learning stipends tied to milestone KPIs.
• Negotiate ecosystem partnerships with ASTAR institutes, local CDMOs, and Temasek-linked venture funds. Act as company spokesperson at global geroscience consortia and Singapore Week of Innovation & Technology (SWITCH).

Job Requirements:

A. Experience

• > 8 years senior leadership (VP, GM, or C-suite) in venture-backed therapeutics or diagnostic start-ups.
• Demonstrable full-cycle advancement of at least one aging-modulation asset to IND or CE-IVD/510(k) filing.
• Hands-on responsibilities for raising > US$5 million in external capital.
• Direct oversight of multi-jurisdictional regulatory filings (HSA plus at least one of GDA/EMA/MHRA).

B. Technical Exposure

• Working familiarity with geroprotective modalities (e.g., NAD+ boosters, senolytics, epigenetic reprogramming, telomere maintenance) and associated CMC challenges (viral-vector or LNP delivery, sterile-fill finish, stability).
• Competence in drafting data-room materials for longevity VC due diligence and sovereign-wealth co-investment.

C. Leadership & Soft Skills

• Strategic thinker capable of translating complex biology into investable milestones under tight capital constraints.
• Adept at navigating matrixed, cross-time zone governance structures and high-velocity change environments.
• Uncompromising professional ethics and risk-management discipline.

D. Mobility

• Willing to undertake frequent travel (up to 40%) to the UK, EU, and US for board meetings, clinical-site qualification, and partner negotiations.
• After-hours availability for global time-zone calls, coordination with Europe/US, and readiness for urgent board interventions.